Skip to Main Content

Paper Details

Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
1
2023
Author NameAffiliation
George D YancopoulosRegeneron Pharmaceuticals Inc.
Jesper GromadaRegeneron Pharmaceuticals Inc.
  • 1 - 2

Datasets

Release 1.2